Cargando…

Lecanemab: A hope in the management of Alzheimer’s disease

Detalles Bibliográficos
Autores principales:	Thakkar, Nandita, Martis, Preetham Basil, Kutikuppala, L. V. Simhachalam, Kuchana, Sai Kiran, Mohapatra, Ranjan K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2023
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679628/ https://www.ncbi.nlm.nih.gov/pubmed/38020956 http://dx.doi.org/10.4103/bc.bc_10_23

Ejemplares similares

Breakthrough in the scientific world: Lab-grown red blood cells used in transfusions
por: Kale, Sampreeti Sri Sai, et al.
Publicado: (2023)

Reply: Unblinding in the lecanemab trial in Alzheimer’s disease
por: Hardy, John, et al.
Publicado: (2023)

Current State-of-the-art Cutting-edge Technologies for Nanonutraceuticals in Cancer
por: Kutikuppala, L. V. Simhachalam, et al.
Publicado: (2023)

Reply: Lecanemab: turning point, or status quo? An ethics perspective
por: Hardy, John, et al.
Publicado: (2023)

An extremely rare case of feeding jejunostomy proceeding to intussusception
por: Nulukurthi, Taraka Krishna, et al.
Publicado: (2023)

Blood Donation during COVID-19 Vaccination drive - The Need for Concern
por: Suvvari, Tarun Kumar, et al.
Publicado: (2021)

Mucormycosis: A killer in the shadow of COVID-19
por: Suvvari, Tarun Kumar, et al.
Publicado: (2021)

Another neglected tropical disease yellow fever re-emerges in African countries: Potential threat in the COVID-19 era which needs comprehensive investigations – Correspondence
por: Mohapatra, Ranjan K., et al.
Publicado: (2022)

The affordability of lecanemab, an amyloid-targeting therapy for Alzheimer's disease: an EADC-EC viewpoint
por: Jönsson, Linus, et al.
Publicado: (2023)

The recent H3N2 viral outbreak in India, 2023: Is it worrying?
por: Boppana, Harsha, et al.
Publicado: (2023)

The Potential Economic Value of Lecanemab in Patients with Early Alzheimer’s Disease Using Simulation Modeling
por: Tahami Monfared, Amir Abbas, et al.
Publicado: (2022)

Estimated Societal Value of Lecanemab in Patients with Early Alzheimer’s Disease Using Simulation Modeling
por: Tahami Monfared, Amir Abbas, et al.
Publicado: (2023)

COVID-19 Era and the Constantly Reemerging Novel SARS-CoV-2 Variants Calls for Special Attention for the Geriatrics: A Real Challenge
por: Kutikuppala, L. V. Simhachalam, et al.
Publicado: (2022)

Long-Term Health Outcomes of Lecanemab in Patients with Early Alzheimer’s Disease Using Simulation Modeling
por: Tahami Monfared, Amir Abbas, et al.
Publicado: (2022)

Predicting the Societal Value of Lecanemab in Early Alzheimer’s Disease in Japan: A Patient-Level Simulation
por: Igarashi, Ataru, et al.
Publicado: (2023)

ARIA in patients treated with lecanemab (BAN2401) in a phase 2 study in early Alzheimer's disease
por: Honig, Lawrence S., et al.
Publicado: (2023)

Safety and efficacy of lecanemab for Alzheimer's disease: a systematic review and meta-analysis of randomized clinical trials
por: Qiao, Yue, et al.
Publicado: (2023)

Emerging pneumonia-like illness “legionellosis” in Argentina in the COVID-19 era: Cause to panic?
por: Mohapatra, Ranjan K., et al.
Publicado: (2022)

Novel anti-amyloid-beta (Aβ) monoclonal antibody lecanemab for Alzheimer’s disease: A systematic review
por: Chowdhury, Selia, et al.
Publicado: (2023)

Effect of Lecanemab and Donanemab in Early Alzheimer’s Disease: Mechanistic Interpretation in the Amyloid Cascade Hypothesis 2.0 Perspective
por: Volloch, Vladimir, et al.
Publicado: (2023)

Impact of Anti-amyloid-β Monoclonal Antibodies on the Pathology and Clinical Profile of Alzheimer’s Disease: A Focus on Aducanumab and Lecanemab
por: Shi, Mingchao, et al.
Publicado: (2022)

Population pharmacokinetic‐pharmacodynamic analyses of amyloid positron emission tomography and plasma biomarkers for lecanemab in subjects with early Alzheimer's disease
por: Hayato, Seiichi, et al.
Publicado: (2022)

Resurging dengue cases among the Rohingya refugees in Bangladesh amid COVID-19 pandemic: A SouthEast Asia healthcare concern
por: Mohapatra, Ranjan K., et al.
Publicado: (2022)

A Path to Improved Alzheimer’s Care: Simulating Long-Term Health Outcomes of Lecanemab in Early Alzheimer’s Disease from the CLARITY AD Trial
por: Tahami Monfared, Amir Abbas, et al.
Publicado: (2023)

Anti-amyloid-β Monoclonal Antibodies as Promising Disease-Modifying Therapies in Alzheimer’s Disease: A Focus on Aducanumab, Lecanemab, Crenezumab, Gantenerumab and Solanezumab
por: Melo, V. S. D., et al.
Publicado: (2023)

Lecanemab reduces brain amyloid-β and delays cognitive worsening
por: Knopman, David S.
Publicado: (2023)

Consistency of efficacy results across various clinical measures and statistical methods in the lecanemab phase 2 trial of early Alzheimer’s disease
por: Dhadda, Shobha, et al.
Publicado: (2022)

Lecanemab for Patients With Early Alzheimer Disease: Bayesian Analysis of a Phase 2b Dose-Finding Randomized Clinical Trial
por: Berry, Donald A., et al.
Publicado: (2023)

Hemisection-hope for last survival
por: Hasija, Mukesh, et al.
Publicado: (2013)

Hope Hospital
por: Taylor, J. H.
Publicado: (1909)

High Hopes ... for General (Internal) Medicine
por: Gray, David
Publicado: (1994)

Colchicine for COVID-19: Hype or hope?
por: Kow, Chia Siang, et al.
Publicado: (2022)

Lecanemab, Aducanumab, and Gantenerumab — Binding Profiles to Different Forms of Amyloid-Beta Might Explain Efficacy and Side Effects in Clinical Trials for Alzheimer’s Disease
por: Söderberg, Linda, et al.
Publicado: (2022)

Roadblocks and COVID-19: Hope and Strict Control
por: Joob, Beuy, et al.
Publicado: (2020)

Hydroxychloroquine (HCQ): real treatment or false hope?
por: El Bakkouri, Karim
Publicado: (2021)

Chronotherapy of cardiovascular pathologies: a hopeful strategy
por: Simko, Fedor, et al.
Publicado: (2022)

High Dose Steroid Therapy to Prevent Severe Hypoxia in COVID-19 Patients: A Potential Solution for Low Resource Clinical Setting
por: Edara, Lokesh, et al.
Publicado: (2020)

Monkeypox Epidemic: A Throwback From Smallpox Eradication
por: Bethineedi, Lakshmi Deepak, et al.
Publicado: (2022)

Commentary on A brief hope intervention to increase hope level and improve well-being in rehabilitating cancer patients: A feasibility test
por: Laranjeira, Carlos A., et al.
Publicado: (2020)

Health-Related Quality of Life in Adolescents with Congenital Heart Disease: Importance of Parental Hope
por: WANG, Xiaoyan
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_mjmu60sou4q86glchok619c8s3